MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Xenon Pharmaceuticals Company Profile (NASDAQ:XENE)

Consensus Ratings for Xenon Pharmaceuticals (NASDAQ:XENE) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.50 (121.37% upside)

Analysts' Ratings History for Xenon Pharmaceuticals (NASDAQ:XENE)
Show:
DateFirmActionRatingPrice TargetActions
5/11/2016Jefferies GroupReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016Canaccord GenuityReiterated RatingBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2015SEB Equity ResearchReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2014Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/31/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha